Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing
- PMID: 15677478
- DOI: 10.1074/jbc.M500476200
Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing
Abstract
ADAR1 (adenosine deaminase acting on RNA) is widely expressed in adult mammals and has a critical role during embryogenesis. Two size forms of ADAR1 are known that possess adenosine-to-inosine editing activity: an interferon (IFN)-inducible approximately 150-kDa protein and a constitutively expressed N-terminally truncated approximately 110-kDa protein. We defined the structure of the 5'-flanking region of the mouse Adar1 gene, and we show here that mouse Adar1 transcripts possess alternative exon 1 structures (1A, 1B, and 1C) that initiate from unique promoters and are spliced to a common exon 2 junction. Exon 1A-containing transcripts encoding p150 were expressed in all tissues examined from adult mice (brain, cecum, heart, kidney, liver, lung, spleen, and Peyer's patches) and were elevated most significantly in liver but remained lowest in brain following oral infection with Salmonella. Exon 1B-containing RNA was most abundant in brain and was not increased in any tissue examined following infection. Exon 1C-containing RNA was very scarce. Exon 1A, but not exon 1B or 1C, expression was increased in fibroblast L cells treated with IFN, and a consensus ISRE element was present in the promoter driving exon 1A expression. Exon 1B, but not 1A, was detectable in embryonic day 10.5 embryos and was abundantly expressed in embryonic day 15 embryos. Furthermore, the ADAR1 p110 protein isoform was detected in embryonic tissue, whereas both p110 and the inducible p150 proteins were found in IFN-treated L cells. Finally, the presence of alternative exon 7a correlated with exon 1B-containing RNA, and alternative exon 7b correlated with exon 1A-containing RNA. These results establish that multiple promoters drive the expression of the Adar1 gene in adult mice, that the IFN inducible promoter and exon 1A-containing RNA are primarily responsible for the increased ADAR1 observed in Salmonella-infected mice, and that the constitutive exon 1B-containing transcript and encoded p110 protein product are abundantly expressed both in adult brain and during embryogenesis.
Similar articles
-
An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).J Interferon Cytokine Res. 2014 Jun;34(6):437-46. doi: 10.1089/jir.2014.0001. J Interferon Cytokine Res. 2014. PMID: 24905200 Free PMC article. Review.
-
Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible.Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4621-6. doi: 10.1073/pnas.96.8.4621. Proc Natl Acad Sci U S A. 1999. PMID: 10200312 Free PMC article.
-
Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation.J Biol Chem. 2003 Nov 14;278(46):45833-42. doi: 10.1074/jbc.M308612200. Epub 2003 Sep 3. J Biol Chem. 2003. PMID: 12954622
-
Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter.Gene. 2000 Nov 27;258(1-2):165-72. doi: 10.1016/s0378-1119(00)00368-1. Gene. 2000. PMID: 11111054
-
Adenosine deaminases acting on RNA, RNA editing, and interferon action.J Interferon Cytokine Res. 2011 Jan;31(1):99-117. doi: 10.1089/jir.2010.0097. Epub 2010 Dec 23. J Interferon Cytokine Res. 2011. PMID: 21182352 Free PMC article. Review.
Cited by
-
RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.PLoS Genet. 2021 May 13;17(5):e1009516. doi: 10.1371/journal.pgen.1009516. eCollection 2021 May. PLoS Genet. 2021. PMID: 33983932 Free PMC article.
-
Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression.Cancer Med. 2016 Sep;5(9):2629-40. doi: 10.1002/cam4.825. Epub 2016 Aug 3. Cancer Med. 2016. PMID: 27485054 Free PMC article.
-
Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.Clin Exp Immunol. 2014 Jan;175(1):9-16. doi: 10.1111/cei.12147. Clin Exp Immunol. 2014. PMID: 23713592 Free PMC article. Review.
-
Molecular model linking Th2 polarized M2 tumour-associated macrophages with deaminase-mediated cancer progression mutation signatures.Scand J Immunol. 2019 May;89(5):e12760. doi: 10.1111/sji.12760. Epub 2019 Mar 18. Scand J Immunol. 2019. PMID: 30802996 Free PMC article.
-
An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).J Interferon Cytokine Res. 2014 Jun;34(6):437-46. doi: 10.1089/jir.2014.0001. J Interferon Cytokine Res. 2014. PMID: 24905200 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials